Park Na Rae Scandal: Workplace Abuse & Illegal Meds

The South Korean entertainment industry is bracing for another major legal battle. Beloved personality Park Na Rae is scheduled to undergo her third police investigation by the Seoul Gangnam Police Station in May 2026. This upcoming probe centers on a series of severe allegations that have shocked fans and industry insiders alike.

Workplace Abuse Allegations

In December, former managers filed lawsuits against the star, bringing forward a string of disturbing accusations. These claims highlight ongoing discussions about workplace dynamics within the K-entertainment sphere. The formal charges filed against her include:

  • Workplace harassment
  • Physical abuse
  • Special injury
  • Defamation

However, Park Na Rae has firmly denied all accusations of mistreatment. Taking a strong legal stance, she has filed a countersuit against her former managers. Her legal team is officially accusing them of attempted extortion and occupational embezzlement.

The “Injection Aunt” Controversy

Adding to the legal turbulence, Park Na Rae is also facing scrutiny over alleged illegal medical procedures. She is accused of receiving IV drips and psychotropic drugs from an unlicensed practitioner. In South Korea, these unauthorized medical figures are colloquially known as an “Injection Aunt.”

While her representatives attempted to defend the situation, medical associations quickly stepped in. They confirmed that the practitioner involved does not hold a valid domestic medical license, directly refuting the agency’s claims. These unfolding events compound her legal woes, which recently included headlines about the Supreme Court upholding a 2-year prison sentence in a Park Na Rae home burglary case.

As May 2026 approaches, the public eagerly awaits the outcome of this complex legal dispute. The results could have significant ripple effects across the entire industry. What are your thoughts on this unfolding controversy? Share your opinions with us in the comments below!

Share the Post:

Write A Comment